507 results on '"Jullien, Denis"'
Search Results
2. Cutaneous calciphylaxis of the glans penis presenting as a gangrenous ulceration
3. Elevating the Standard of Care for Patients with Psoriasis: ‘Calls to Action’ from Epicensus, a Multistakeholder Pan-European Initiative
4. Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method
5. Correction to: The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study
6. Multiple acantholytic dyskeratotic acanthomas in a liver-transplant recipient
7. Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patients
8. The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis
9. Multifocal lymphangioendotheliomatosis with thrombocytopenia: report of a case with favorable outcome into adulthood
10. Effect of High-Dose Subcutaneous Spesolimab on Skin Manifestations: Results from the Pivotal Effisayil 2 Trial of Flare Prevention in Generalized Pustular Psoriasis
11. Follicular Porokeratoma: Report of a New Variant of Porokeratoma (Porokeratotic Acanthoma) and Literature Review
12. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
13. Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
14. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
15. Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab
16. Condyloma acuminatum of the nipple, an unusual presentation
17. Use of Complementary and Alternative Medicines by Patients with Psoriasis: Results from a Study with 2562 Patients
18. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores
19. A recent nodule on the forehead
20. Flare Frequency and Duration in Patients with Generalized Pustular Psoriasis (GPP)
21. Dermpath & Clinic: Lichen planus pemphigoides
22. Immune-mediated skin diseases induced by chemicals and drugs
23. Biosimilars for Psoriasis—Experience from Europe
24. Dermpath & Clinic: Cellular neurothekeoma mimicking pyogenic granuloma
25. Psoriasis and COVID-19: findings from PsoProtectMe.
26. 3D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System
27. Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial
28. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
29. Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab.
30. The usefulness of omalizumab in low response to corticosteroids DRESS syndrome: A case series
31. Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohort
32. Supplementary Figure 2 from Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery
33. Supplementary Figure 1 from Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery
34. Data from Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery
35. Supplementary Table 1 from Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery
36. Out‐of‐pocket expenditures in adult patients with prurigo nodularis in France
37. Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2):number needed to harm for occurrence of adverse events of special interest
38. Elevating the Standard of Care for Patients with Psoriasis:‘Calls to Action’ from Epicensus, a Multistakeholder Pan-European Initiative
39. Macrocyclic Lactones Block Melanoma Growth, Metastases Development and Potentiate Activity of Anti–BRAF V600 Inhibitors
40. Evidence for Human CD4+ T Cells in the CD1-Restricted Repertoire: Derivation of Mycobacteria-Reactive T Cells from Leprosy Lesions
41. A severe facial dermatosis.
42. 3-D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System (MANTIS)
43. Elevating the Standard of Care for Patients with Psoriasis: ‘Calls to Action’ from Epicensus, a Multistakeholder Pan-European Initiative
44. Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special interest
45. sQUIZ your knowledge!: A recent red lesion on the forearm
46. Dermpath & clinic: Pigmented epithelioid melanocytoma
47. Inducible degradation of the Drosophila Mediator subunit Med19 reveals its role in regulating developmental but not constitutively-expressed genes
48. Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial
49. Auxin-induced (AID) protein degradation in drosophila larvae v1
50. 33356 A multinational chart review to examine gastrointestinal symptoms and their management in patients treated with apremilast for plaque psoriasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.